Home Response to comments on ‘sensitivity of estimands in clinical trials with imperfect compliance’
Article
Licensed
Unlicensed Requires Authentication

Response to comments on ‘sensitivity of estimands in clinical trials with imperfect compliance’

  • Heng Chen and Daniel F. Heitjan EMAIL logo
Published/Copyright: May 6, 2024

Received: 2024-02-08
Accepted: 2024-03-27
Published Online: 2024-05-06

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Research Articles
  3. Random forests for survival data: which methods work best and under what conditions?
  4. Flexible variable selection in the presence of missing data
  5. An interpretable cluster-based logistic regression model, with application to the characterization of response to therapy in severe eosinophilic asthma
  6. MBPCA-OS: an exploratory multiblock method for variables of different measurement levels. Application to study the immune response to SARS-CoV-2 infection and vaccination
  7. Detecting differentially expressed genes from RNA-seq data using fuzzy clustering
  8. Hypothesis testing for detecting outlier evaluators
  9. Response to comments on ‘sensitivity of estimands in clinical trials with imperfect compliance’
  10. Commentary
  11. Comments on “sensitivity of estimands in clinical trials with imperfect compliance” by Chen and Heitjan
  12. Research Articles
  13. Optimizing personalized treatments for targeted patient populations across multiple domains
  14. Statistical models for assessing agreement for quantitative data with heterogeneous random raters and replicate measurements
  15. History-restricted marginal structural model and latent class growth analysis of treatment trajectories for a time-dependent outcome
  16. Revisiting incidence rates comparison under right censorship
  17. Ensemble learning methods of inference for spatially stratified infectious disease systems
  18. The survival function NPMLE for combined right-censored and length-biased right-censored failure time data: properties and applications
  19. Hybrid classical-Bayesian approach to sample size determination for two-arm superiority clinical trials
  20. Estimation of a decreasing mean residual life based on ranked set sampling with an application to survival analysis
  21. Improving the mixed model for repeated measures to robustly increase precision in randomized trials
  22. Bayesian second-order sensitivity of longitudinal inferences to non-ignorability: an application to antidepressant clinical trial data
  23. A modified rule of three for the one-sided binomial confidence interval
  24. Kalman filter with impulse noised outliers: a robust sequential algorithm to filter data with a large number of outliers
  25. Bayesian estimation and prediction for network meta-analysis with contrast-based approach
  26. Testing for association between ordinal traits and genetic variants in pedigree-structured samples by collapsing and kernel methods
Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ijb-2024-0013/html
Scroll to top button